Department of General Thoracic Surgery, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
Surg Today. 2021 Aug;51(8):1320-1327. doi: 10.1007/s00595-021-02231-7. Epub 2021 Feb 6.
To investigate the relationship between three-dimensional computed tomography (3D-CT) findings and pathological invasiveness in lung adenocarcinoma.
We retrospectively evaluated 95 patients who underwent surgical resection of lung adenocarcinoma of ≤ 20 mm. The diameters, volumes, and CT values of tumor consolidation were analyzed. We defined the modified CT value by setting air as 0 and water as 1000 and assumed a correlation with pathological invasiveness. Pre-invasive lesions and minimally invasive adenocarcinomas were classified as non-invasive adenocarcinoma. We compared the clinico-radiological features with pathological invasiveness. Receiver operator characteristic (ROC) curves and recurrence-free survival curves were constructed.
Twenty-six non-invasive adenocarcinomas and 69 invasive adenocarcinomas were evaluated. The multivariate analysis revealed that the consolidation volume and the integration of modified CT values were the most important predictors of pathological invasion. The area under the ROC curve and the cut-off values of the consolidation volume were 0.868 and 75 mm, respectively. The area under the ROC curve and the cut-off values of the integration of modified CT values were 0.871 and 80,000, respectively. There was no recurrence in cases with values below the cut-off across all parameters.
The consolidation volume and integration of modified CT values were shown to be highly predictive of pathological invasiveness.
探讨肺腺癌三维 CT(3D-CT)表现与病理侵袭性的关系。
我们回顾性评估了 95 例接受≤20mm 肺腺癌手术切除的患者。分析了肿瘤实变的直径、体积和 CT 值。我们通过将空气设定为 0,水设定为 1000 来定义修正 CT 值,并假设其与病理侵袭性相关。将前侵袭性病变和微侵袭性腺癌归类为非侵袭性腺癌。我们比较了临床影像学特征与病理侵袭性。构建了受试者工作特征(ROC)曲线和无复发生存曲线。
评估了 26 例非侵袭性腺癌和 69 例侵袭性腺癌。多变量分析显示,实变体积和修正 CT 值的综合是病理侵袭性的最重要预测因子。ROC 曲线下面积和实变体积的截断值分别为 0.868 和 75mm。修正 CT 值综合的 ROC 曲线下面积和截断值分别为 0.871 和 80,000。在所有参数中,低于截断值的病例均无复发。
实变体积和修正 CT 值的综合可高度预测病理侵袭性。